Breaking News
0

Novo Nordisk A/S (NVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novo Nordisk ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
48.72 -0.27    -0.55%
18/05 - Closed. Currency in USD ( Disclaimer )
After Hours
48.72
0.00
0.00%
16:41:33 - Real-time Data
Type: Equity
Market: United States
ISIN: US6701002056 
CUSIP: 670100205
  • Volume: 868,886
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 48.29 - 48.74
Novo Nordisk ADR 48.72 -0.27 -0.55%

NVO Overview

 
Information about the Novo Nordisk A/S Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close48.99
Day's Range48.29 - 48.74
Revenue21.91B
Open48.38
52 wk Range41.03 - 58.37
EPS2.48
Volume868,886
Market Cap93.88B
Dividend (Yield)1.14 (2.34%)
Average Vol. (3m)1,454,101
P/E Ratio19.61
Beta0.7
1-Year Change19.27%
Shares Outstanding2,394,000,000
Next Earnings DateAug 08, 2018
What is your sentiment on Novo Nordisk ADR?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S News


Novo Nordisk A/S - Share repurchase programme
Novo Nordisk A/S - Share repurchase programme
By GlobeNewswire - May 14, 2018

Bagsværd, Denmark, 14 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European...

Trump speech on drug prices light on specifics
Trump speech on drug prices light on specifics By Seeking Alpha - May 11, 2018

Key points from President Trump's speech detailing his plan to lower U.S. drug prices called American Patients First:Bans pharmacist gag rule against advising patients on...

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Sell Buy
Technical Indicators Strong Buy Strong Buy Sell Sell Strong Buy
Summary Strong Buy Strong Buy Neutral Sell Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Abandoned Baby Bearish 1D 3 May 15, 2018
Evening Doji Star 1D 3 May 15, 2018
Doji Star Bearish 1D 4 May 14, 2018
Three White Soldiers 30 8 May 18, 2018 11:30AM
Engulfing Bearish 5H 9 May 14, 2018 11:00AM

Novo Nordisk A/S Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 48.72 0.00 0.00 868,886 -0.55% USD 18/05  
  BATS Europe 307.0 0.0 0.0 490,104 -0.76% DKK 18/05  
  London 308.60 0.00 0.00 222,074 +0.34% DKK 18/05  
  Mexico 960.710 0.000 0.000 229 +0.21% MXN 18/05  
  Switzerland 48.640 0.000 0.000 0 0.00% CHF 16/05  
  Xetra 41.30 41.05 41.48 11,471 -0.48% EUR 18/05  
  Berlin 41.360 0.000 0.000 0 +0.56% EUR 18/05  
  Munich 41.300 0.000 0.000 2,300 +0.34% EUR 18/05  
  Berlin 41.400 41.300 41.400 0 +0.24% EUR 18/05  
  Xetra 40.3000 40.9000 41.3000 1,800 0.00% EUR 18/05  
  Frankfurt 41.12 0.00 0.00 11,156 -0.83% EUR 18/05  
  Stuttgart 41.260 0.000 0.000 3,102 -0.27% EUR 18/05  
  Real-time CFD 306.8 - - - -0.90% DKK 18/05  
  Copenhagen 306.80 0.00 0.00 1,886,078 -0.90% DKK 18/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 186.31 187.81 186.13 -0.68 -0.36% 18.30M 18/05  
  Tata Steel Ltd 591.40 616.70 590.35 -18.90 -3.10% 8.22M 18/05  
  Amazon.com 1,574.37 1,583.59 1,572.10 -7.39 -0.47% 2.64M 18/05  
  Reliance Industries 933.85 953.50 932.00 -11.50 -1.22% 5.23M 18/05  
  Tesla 276.82 284.65 274.00 -7.72 -2.71% 7.25M 18/05  
  Facebook 182.68 184.19 182.61 -1.08 -0.59% 13.13M 18/05  
  SBI 238.85 244.00 237.85 -3.85 -1.59% 11.87M 18/05  
  Tata Motors 304.60 315.00 303.50 -10.30 -3.27% 11.69M 18/05  
  Bajaj Finance 2,149.65 2,171.75 2,065.65 +83.15 +4.02% 8.32M 18/05  
  Alibaba 195.00 197.78 194.72 -1.02 -0.52% 14.24M 18/05  

Novo Nordisk A/S Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

42688

Equity Type

ADR

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVO Comments

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email